Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game

References

• Werb Z, Coussens LM. Inflammation and cancer. Nature. 2002;420:860–867.
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med. 2006;79(3–4):123–130.
   PubMedGoogle Scholar
• Lu H, Ouyang W, Huang C. Inflammation, a Key event in cancer development. Mol Cancer Res. 2006;4:221–223.
   PubMed Web of Science ®Google Scholar
• Serhan CN, Brain SD, Buckley CD, et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007;21(2):325–332.
   PubMed Web of Science ®Google Scholar
• Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013;5(5):661–674.
   PubMed Web of Science ®Google Scholar
• Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP. The resolution of inflammation. Nat Rev Immunol. 2013;13, 59–66.
   PubMed Web of Science ®Google Scholar
• Kumar V, Sharma A. Mast cells: emerging innate immune cells with diverse role in immunity. Mol Immunol. 2010;48(1–3):14–25.
   PubMed Web of Science ®Google Scholar
• Kumar V, Sharma A. Neutrophils: Cinderella of innate immune system. International Immunopharmacology. 2010;10(11):1325–1334.
   PubMed Web of Science ®Google Scholar
• Kantari C, Pederzoli-Ribeil M, Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity. Contrib Microbiol. 2008;15:118–146.
   PubMedGoogle Scholar
• Fattahi F, Ward PA. Anti-inflammatory interventions-what has been worked, not worked, and what may work in future. Transl Res. 2016;167(1):1–6.
   PubMed Web of Science ®Google Scholar
• Hosac AM. Drotrecogin alfa (activated): the first FDA-approved treatment for severe sepsis. Proc (Bayl Univ Med Cent). 2002;15(2):224–227.
   PubMedGoogle Scholar
• Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366(22):2055–2064.
   PubMed Web of Science ®Google Scholar
• Hams E, Bermingham R, Fallon PG. Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis. Front Immunol. 2015;6:597.
   PubMed Web of Science ®Google Scholar
• Kumar V. Innate lymphoid cells: new paradigm in immunology of inflammation. Immunol Lett. 2014;157(1–2):23–37.
   PubMed Web of Science ®Google Scholar
• Kumar V. Innate lymphoid cells: immunoregulatory cells of mucosal inflammation. European Journal of Inflammation. 2014;12(1):11–20.
   Web of Science ®Google Scholar
• Gapin L. Where do MAIT cell fit in the family of unconventional T cells? PLoS Biol. 2009;7(3):e1000070 (0435–0438).
   Web of Science ®Google Scholar
• Liuzzi AR, McLaren JE, Price DA, Eberl M. Early innate responses to pathogens: pattern recognition by unconventional human T-cells. Curr Opin Immunol. 2015;36:31–37.
   PubMed Web of Science ®Google Scholar
• Huang S. Targeting innate-like T cells in tuberculosis. Frontiers Immunol. 2016;7:594.
   PubMed Web of Science ®Google Scholar
• Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med. 1993;178(1):1–16.
   PubMed Web of Science ®Google Scholar
• Treiner E, Duban L, Bahram S, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928):164–169.
   PubMed Web of Science ®Google Scholar
• Gao Y., Williams AP. Role of innate T cells in anti-bacterial immunity. Front Immunol. 2015;6:Article 302. doi:10.3389/fimmu.2015.00302. PMID:26124758
   PubMed Web of Science ®Google Scholar
• Mori L, Lepore M, De Libero G. The Immunology of CD1- and MR1-Restricted T Cells. Annu Rev Immunol. 2016;34:479–510.
   PubMed Web of Science ®Google Scholar
• Ussher JE, Klenerman P, Willberg CB. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol. 2014;5:450. eCollection 2014 doi:10.3389/fimmu.2014.00450.
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB. The burgeoning family of unconventional T cells. Nat Immunol. 2015;16(11):1114–1123.
   PubMed Web of Science ®Google Scholar
• Cowley SC. MAIT Cells and pathogen defense. Cell Mol Life Sci. 2014;71:4831–4840.
   PubMed Web of Science ®Google Scholar
• Boudinot P, Mondot S, Jouneau L, Teyton L, Lefranc MP, Lantz O. Restricting non classical MHC genes coevolve with TRAV genes used by innate-like T cells in mammals. Proc Natl Acad Sci U S A. 2016;113(21):E2983–E2992.
   PubMed Web of Science ®Google Scholar
• Mondot S, Boudinot P, Lantz O. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules? Immunogenetics. 2016;68(8):537–548.
   PubMed Web of Science ®Google Scholar
• Reantragoon R, Corbett AJ, Sakala IG, et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med. 2013;210(11):2305–2320.
   PubMed Web of Science ®Google Scholar
• Gold MC, McLaren JE, Reistetter JA, et al. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. J Exp Med. 2014;211(8):1601–1610.
   PubMed Web of Science ®Google Scholar
• Lepore M, Kalinichenko A, Colone A, et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. Nat Commun. 2014;5:3866.
   PubMed Web of Science ®Google Scholar
• Treiner E, Duban L, Moura IC, Hansen T, Gilfillan S, Lantz O. Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect. 2005;7(3):552–559.
   PubMed Web of Science ®Google Scholar
• Martin E, Treiner E, Duban L, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol 2009;7:e54.
   PubMed Web of Science ®Google Scholar
• Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic resistant, tissue-targeted, CD161hi IL-17 secreting T cells. Blood. 2011;117:1250–1259.
   PubMed Web of Science ®Google Scholar
• Walker LJ, Kang YH, Smith MO, et al. Human MAIT and CD8alpha cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 2012;119:422–433.
   PubMed Web of Science ®Google Scholar
• Billerbeck E, Kanh YH, Walker L, et al. Analysis of CD161 expression of human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci USA. 2010;107(7):3006–3011.
   PubMed Web of Science ®Google Scholar
• Turtle CJ, Delrow J, Joslyn RC, et al. Innate signals overcome acquired TCR signalling pathway regulation and govern the fate of human CD161(hi) CD8alpha semi-invariant T cells. Blood. 2011;118:2752–2762.
   PubMed Web of Science ®Google Scholar
• Gold MC, Eid T, Smyk-Pearson S, et al. Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol. 2013;6(1):35–44.
   PubMed Web of Science ®Google Scholar
• Koay HF, Gherardin NA, Enders A, et al. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat Immunol. 2016;17(11):1300–1311.
   PubMed Web of Science ®Google Scholar
• Gold MC, Lewinsohn DM. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol. 2013;11:14–19.
   PubMed Web of Science ®Google Scholar
• Gold MC, Lewinsohn DM. Mucosal-associated invariant T-cells and the immune response to infection. Microbes and Infection. 2011;13:742–748.
   PubMed Web of Science ®Google Scholar
• Howson LJ, Salio M, Cerundolo V. MR1-restircted mucosal-associated invariant T cells and their activation during infectious diseases. Front Immunol. 2015;6:Article 303. doi:10.3389/fimmu.2015.00303. PMID:26136743
   PubMed Web of Science ®Google Scholar
• Huang S, Gilfillan S, Kim S, et al. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med. 2008;205(5):1201–1211.
   PubMed Web of Science ®Google Scholar
• Martin E, Treiner E, Duban L, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol 2009;7:e54.
   PubMed Web of Science ®Google Scholar
• Walker LJ, Kang YH, Smith MO, et al. Human MAIT and CD8alpha cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 2012;119:422–433.
   PubMed Web of Science ®Google Scholar
• Le Bourhis L, Mburu YK, Lantz O. MAIT cells, Surveyors of a new class of antigen: development and functions. Curr Opin Immunol. 2013;25:174–180.
   PubMed Web of Science ®Google Scholar
• Arduini S, Dunne J, Conlon N, Feighery C, Doherty DG. Mucosal-associated invariant T cells are depleted and functionally altered in patients with common variable immunodeficiency. Clin Immunol. 2017;176:23–30.
   PubMed Web of Science ®Google Scholar
• Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol. 2011;32(5):212–218.
   PubMed Web of Science ®Google Scholar
• Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic resistant, tissue-targeted, CD161hi IL-17 secreting T cells. Blood. 2011;117:1250–1259.
   PubMed Web of Science ®Google Scholar
• Griewank K, Borowski C, Rietdijk S, et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007;27:751–762.
   PubMed Web of Science ®Google Scholar
• Seach N, Guerri L, Le Bourhis L, et al. Double-positive thymocytes select mucosal-associated invariant T cells. J Immunol. 2013;191(12):6002–6009.
   PubMed Web of Science ®Google Scholar
• Franciszkiewicz K, Salou M, Legoux F, et al. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells. Immunol Rev. 2016;272(1):120–138.
   PubMed Web of Science ®Google Scholar
• Lee OJ, Cho YN, Kee SJ, et al. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults. Exp Gerontol. 2014;49:47–54.
   PubMed Web of Science ®Google Scholar
• Rahimpour A, Koay HF, Enders A, et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Mfed. 2015;212(7):1095–1108.
   PubMed Web of Science ®Google Scholar
• Booth JS, Salerno-Goncalves R, Blanchard TG, et al. Mucosal-associated invariant t cells in the human gastric mucosa and blood: Role in Helicobacter pylori infection. Front Immunol. 2015;6:466.
   PubMed Web of Science ®Google Scholar
• Le Bourhis L, Martin E, Péguillet I, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 2010;11:701–708.
   PubMed Web of Science ®Google Scholar
• Jenny NS. Inflammation in aging: cause, effect, or both? Discov Med. 2012;13(73):451–460.
   PubMed Web of Science ®Google Scholar
• Lepore M, Kalinichenko A, Colone A, et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. Nat Commun. 2014;5:3866.
   PubMed Web of Science ®Google Scholar
• Gibbs A, Leeansyah E, Introini A, et al. Expression of MAIT Cells in Blood and Genital Mucosa of HIV Infected and Uninfected Women. AIDS Res Hum Retroviruses. 2014;30(S1):A47–A48.
   Google Scholar
• Gibbs A, Leeansyah E, Introini A, et al. MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation. Mucosal Immunol. 2017;10(1):35:45. doi:10.1038/mi.2016.30. PMID:27049062
   PubMed Web of Science ®Google Scholar
• Gold MC, Cerri S, Smyk-Pearson S, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010;8(6):e1000407.
   PubMed Web of Science ®Google Scholar
• van Wilgenburg B, Scherwitzl I, Hutchinson EC, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653.
   PubMed Web of Science ®Google Scholar
• Loh L, Wang Z, Sant S, et al. Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation. Proc Natl Acad Sci USA. 2016;113(36):10133–10138.
   PubMed Web of Science ®Google Scholar
• Wong EB, Ndung'u T, Kasprowicz VO. The role of mucosal-associated invariant T cells in infectious diseases. Immunology. 2017;150(1):45–54.
   PubMed Web of Science ®Google Scholar
• Kjer-Nielsen L, Patel O, Corbett AJ, et al. MR1 presents vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717–723.
   PubMed Web of Science ®Google Scholar
• Corbett AJ, Eckle SB, Birkinshaw RW, et al. T cell activation by transitory neo-antigens from distinct microbial pathways. Nature. 2014;509(7500):361–365.
   PubMed Web of Science ®Google Scholar
• Napier RJ, Adams EJ, Gold MC, Lawinsohn DM. The role of mucosal invariant T cells in antimicrobial immunity. Front Immunol. 2015;6:344.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, D'Souza C, et al. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol. 2017;10:58–68.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Kurosawa Y, Hashimoto K. Expanded genomic organization of conserved mammalian MHC class I-related genes, human MR1 and its murine ortholog. Biochem Biophys Res Commun. 1998;250(3):558–564.
   PubMed Web of Science ®Google Scholar
• Tsukamoto K, Deakin JE, Graves JA, Hashimoto K. Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals. Immunogenetics. 2013;65(2):115–124.
   PubMed Web of Science ®Google Scholar
• Riegert P, Wanner V, Bahram S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J Immunol. 1999;161980:4066–4077.
   Google Scholar
• Chua WJ, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, Hansen TH. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun. 2012;80(9):3256–3267.
   PubMed Web of Science ®Google Scholar
• Meierovics A, Yankelevich WJ, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA. 2013;110(33):E119–E128.
   Web of Science ®Google Scholar
• Meierovics AI, Cowley SC. MAIT cells promote inflammatory monocyte differentiation into dendritic cells during pulmonary intracellular infection. J Exp Med. 2016;213(12):2793–2809.
   PubMed Web of Science ®Google Scholar
• Ussher JE, van Wilgenburg B, Hannaway RF, et al. TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells. Eur J Immunol. 2016;46(7):1600–1614.
   PubMed Web of Science ®Google Scholar
• Patel O, Kjer-Nielsen L, Le Nours J, et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun. 2013;4:2142. doi:10.1038/ncomms3142. PMID:23846752
   PubMed Web of Science ®Google Scholar
• Eckle SB, Birkinshaw RW, Kostenko L, et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J Exp Med. 2014;211(8):1585–1600.
   PubMed Web of Science ®Google Scholar
• Davey MS, Morgan MP, Liuzzi AR, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193(7):3704–3716.
   PubMed Web of Science ®Google Scholar
• Salerno-Goncalves R, Rezwan T, Sztein MB. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4(511):1–15.
   PubMedGoogle Scholar
• Kurioka A, Ussher JE, Cosgrove C, et al. MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol. 2015;8(2):429–440.
   PubMed Web of Science ®Google Scholar
• Gold MC, Napier RJ, Lewinsohn DM. MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev. 2015;264(1):154–166.
   PubMed Web of Science ®Google Scholar
• Jiang J, Wang X, An H, et al. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signalling in patients with active tuberculosis. Am J Respir Crit Care Med. 2014;190(3):329–339.
   PubMed Web of Science ®Google Scholar
• Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signalling. Sci Rep. 2016;6:32320.
   PubMed Web of Science ®Google Scholar
• Jiang J, Yang B, An H, et al. Mucosal-associated invariant T cells from patients with tuberculosis exhibit impaired immune response. J Infect. 2016;72(3):338–352.
   PubMed Web of Science ®Google Scholar
• Wallington JC, Williams AP, Staples KJ, Wilkinson TMA. IL-12 and IL-7 synergise to control MAIT cell cytotoxic responses to bacterial infection. J Allergy Clin Immunol. 2017; Sep 1. pii:S0091-6749(17)31358-1. doi: 10.1016/j.jaci.2017.08.009. [Epub ahead of print].
   Google Scholar
• Greene JM, Dash P, Roy S, et al. MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates. Mucosal Immunol. 2016;10(3):802–813. doi:10.1038/mi.2016.91. [Epub ahead of print] PMID:27759023
   PubMed Web of Science ®Google Scholar
• Kang SJ, Jin HM, Won EJ, et al. Activation, impaired tumor necrosis factor-α production, and deficiency of circulating mucosal-associated invariant T cells in patients with scrub typhus. PLoS Negl Trop Dis. 2016;10(7):e0004832. doi:10.1371/journal.pntd.0004832. PMID:27463223
   PubMed Web of Science ®Google Scholar
• Billerbeck E, Kanh YH, Walker L, et al. Analysis of CD161 expression of human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci USA. 2010;107(7):3006–3011.
   PubMed Web of Science ®Google Scholar
• Barathan M, Mohamed R, Vadivelu J, et al. Peripheral loss of CD8(+)CD161(++)TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients. Eur J Clin Invest. 2016;46(2):170–180.
   PubMed Web of Science ®Google Scholar
• Hengst J, Strunz B, Deterding K, et al. Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy. Eur J Immunol. 2016;46(9):2204–2210.
   PubMed Web of Science ®Google Scholar
• Ussher JE, Phalora P, Cosgrove C, et al. Molecular analyses define Vα7.2-Jα33+ MAIT cell depletion in HIV infection: a case-control study. Medicine (Baltimore). 2015;94(29):e1134.
   PubMed Web of Science ®Google Scholar
• Leeansyah E, Ganesh A, Quigley MF, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 2013;121(7):1124–1135.
   PubMed Web of Science ®Google Scholar
• Cosgrove C, Ussher JE, Rauch A, et al. Early and non-reversible decrease of CD161++/MAIT cells in HIV infection. Blood. 2013;121:951–961.
   PubMed Web of Science ®Google Scholar
• Greathead L, Metcalf R, Gazzard B, Gotch F, Steel A, Kelleher P. CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8þ T-cell immune activation. AIDS. 2014;28:1690–1692.
   PubMed Web of Science ®Google Scholar
• Wong EB, Akilimali NA, Govender P, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One. 2013;8:e83474.
   PubMed Web of Science ®Google Scholar
• Gaardbo JC, Hartling HJ, Thorsteinsson K, Ullum H, Nielsen SD. CD3+ CD8+ CD161 high Tc17 cells are depleted in HIV-infection. Aids. 2013;27:659–662.
   PubMed Web of Science ®Google Scholar
• Saeidi A, Ellegård R, Yong YK, , et al. Functional role of mucosal-associated invariant T cells in HIV infection. J Leukoc Biol. 2016;100(2):305–314.
   PubMed Web of Science ®Google Scholar
• Fernandez CS, Amarasena T, Kelleher AD, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177–188.
   PubMed Web of Science ®Google Scholar
• Leeansyah E, Svärd J, Dias J, et al. Arming of MAIT cell cytolytic antimicrobial activity is induced by IL-7 and defective in HIV-1 infection. PLoS Pathog. 2015 Aug;11(8):e1005072.
   PubMed Web of Science ®Google Scholar
• Khaitan A, Kilberg M, Kravietz A, et al. HIV-infected children have lower frequencies of CD8+ mucosal-associated invariant T (MAIT) cells that correlate with innate, Th17 and Th22 cell subsets. PLoS One. 2016;11(8):e0161786.
   PubMed Web of Science ®Google Scholar
• Chu HX, Arumugam TV, Gelderblom M, et al. Role of CCR2 in inflammatory conditions of the central nervous system. J Cereb Blood Flow Metab. 2014;34(9):1425–1429
   PubMed Web of Science ®Google Scholar
• McWilliam HEG, Villadangos JA. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells. Trends Immunol. 2017;38(9):679–689.
   PubMed Web of Science ®Google Scholar
• Le Bourhis L, Dusseaux M, Bohineust A, et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog. 2013;9(10):e1003681
   PubMed Web of Science ®Google Scholar
• Grimaldi D, Le Bourhis L, Sauneuf B, et al. Specific MAIT behaviour among innate-like lymphocytes in critically ill patients with severe infections. Intensive Care Med. 2014;40(2):192–201.
   PubMed Web of Science ®Google Scholar
• Meierovics A, Yankelevich WJ, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA. 2013;110(33):E119–E128.
   Web of Science ®Google Scholar
• Jin W, Dong C. IL-17 cytokines in immunity and inflammation. Emerg Microb Infect. 2013;2:e60.
   PubMed Web of Science ®Google Scholar
• Li J, Reantragoon R, Kostenko L, Corbett AJ, Varigos G, Carbone FR. The frequency of mucosal-associated invariant T cells is selectively increased in dermatitis herpetiformis. Aust J Dermatol. 2017:58(3):200–204. Mar 4. doi:10.1111/ajd.12456. [Epub ahead of print]
   Web of Science ®Google Scholar
• Singal A, Bhattacharya SN, Baruah MC. Dermatitis herpetiformis and rheumatoid arthritis. Indian J Dermatol Venereol Leprol. 68(4):229–230.
   PubMedGoogle Scholar
• Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311–322.
   PubMed Web of Science ®Google Scholar
• Turtle CJ, Swanson HM, Fujii N, Estey EH, Riddell SR. A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity. 2009;31:834–844.
   PubMed Web of Science ®Google Scholar
• Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic resistant, tissue-targeted, CD161hi IL-17 secreting T cells. Blood. 2011;117:1250–1259.
   PubMed Web of Science ®Google Scholar
• Havenith SH, Yong SL, Henson SM, et al. Analysis of stem-cell-like properties of human CD161++IL-18Ralpha+ memory CD8+ T cells. Int Immunol 2012;24:625–636.
   PubMed Web of Science ®Google Scholar
• Turtle CJ, Delrow J, Joslyn RC, et al. Innate signals overcome acquired TCR signalling pathway regulation and govern the fate of human CD161(hi) CD8alpha semi-invariant T cells. Blood. 2011;118:2752–2762.
   PubMed Web of Science ®Google Scholar
• Kurioka A, Walker LJ, Klenerman P, Willberg CB. MAIT cells: New guardians of the liver. Clin Transl Immunology. 2016;5(8):e98.
   PubMedGoogle Scholar
• Jo J, Tan AT, Ussher JE, Sandalova E, Tang X-Z, Tan-Garcia A et al. Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS Pathog. 2014;10:e1004210.
   PubMed Web of Science ®Google Scholar
• Ille´s Z, Shimamura M, Newcombe J, Oka N, Yamamura T. Accumulation of Vα7.2-Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol. 2004;16:223–230.
   PubMed Web of Science ®Google Scholar
• Treiner E, Liblau RS. Mucosal associated invariant T cells in multiple sclerosis: the jury is still out. Front Immunol. 2015;6:503.
   PubMed Web of Science ®Google Scholar
• Croxford JL, Miyake S, Huang YY, Shimamura M, Yamamura T. Invariant V(alpha)19iT cells regulate autoimmune inflammation. Nat Immunol. 2006;7(9):987–994.
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol. 2011;23(9):529–535.
   PubMed Web of Science ®Google Scholar
• Annibali V, Ristori G, Angelini DF, et al. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. Brain. 2011;134(Pt 2):542–554.
   PubMedGoogle Scholar
• Willing A, Leach OA, Ufer F, et al. CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol. 2014;44(10):3119–3128.
   PubMed Web of Science ®Google Scholar
• Bianchini E, De Biasi S, Simone AM, et al. Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis. Immunol Lett. 2017;183:1–7.
   PubMed Web of Science ®Google Scholar
• Salou M, Nicol B, Garcia A, et al. Neuropathologic, phenotypic and functional analyses of mucosal associated invariant T cells in multiple sclerosis. Clin Immunol. 2016;166–167:1–11.
   PubMed Web of Science ®Google Scholar
• Sugimoto C, Hirotani M, Yoshikiyo K, et al. The dynamics of mucosal-associated invariant T cells in multiple sclerosis. Springerplus. 2016;5(1):1259.
   PubMedGoogle Scholar
• Wen Z, Fiocchi C. Inflammatory Bowel Disease: Autoimmune or immune-mediated pathogenesis? Clin Develop Immunol. 2004;11(3/4):195–204.
   PubMedGoogle Scholar
• De Souza H, Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13(1):13–27.
   PubMed Web of Science ®Google Scholar
• Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P, et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol. 2014;176(2):266–274.
   PubMed Web of Science ®Google Scholar
• Treiner E. Mucosal-associated invariant T cells in inflammatory bowel disease: bystanders, defenders, or offenders. Front Immunol. 2015;6:27. doi:10.3389/fimmu.2015.00027. https://doi.org/10.3389/fimmu.2015.00027” PMID:25699045
   PubMed Web of Science ®Google Scholar
• Haga K, Chiba A, Shibuya T, et al. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis. J Gastroenterol Hepatol. 2016;31(5):965–972.
   PubMed Web of Science ®Google Scholar
• Hiejima E, Kawai T, Nakase H, et al. Reduced numbers and proapoptotic features of mucosal-associated invariant T cells as a characteristic finding in patients with inflammatory bowel disease. Inflam Bowel Dis. 2015;21(7):1529–1540.
   PubMed Web of Science ®Google Scholar
• Wada J and Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2016;12:13–26.
   PubMed Web of Science ®Google Scholar
• Magalhaes I, Pingris K, Poitou C, et al. Mucosal associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest. 2015;125(4):1752–1762.
   PubMed Web of Science ®Google Scholar
• Magalhaes I, Kiaf B, Lehuen A. iNKT and MAIT cell alterations in diabetes. Front Immunol. 2015;6:341.
   PubMed Web of Science ®Google Scholar
• Cho YN, Kee SJ, Kim TJ, et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J Immunol. 2014;193(8):3891–3901.
   PubMed Web of Science ®Google Scholar
• Riley J. PD-1 signalling in primary T cells. Immunol Rev. 2009;229(1):114–125.
   PubMedGoogle Scholar
• Teunissen MB, Yeremenko NG, Baeten DL, et al. The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol. 2014;134(12):2898–2907.
   PubMed Web of Science ®Google Scholar
• Mortezavi M, Ritchlin C. Immunologic advances reveal new targets in psoriasis and psoriatic arthritis. Discov Med. 2015;20(110):169–175.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Hill GR, Bell SC, Reid DW. Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. PLoS One. 2014;9(10):e109891.
   PubMed Web of Science ®Google Scholar
• Braudeau C, Amouriaux K, Néel A, et al. Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis. J Autoimmun. 2016;70:73–79.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.
   PubMedGoogle Scholar
• Moutsopoulos HM, Chused TM, Mann DL, et al. Sjögren's syndrome (Sicca syndrome): Current issues. Ann Intern Med. 1980;92(2 Pt 1):212–226.
   PubMed Web of Science ®Google Scholar
• Brito-Zeron P, Ramos-Casals M. Advances in the understanding and treatment of systemic complications in Sjogren's syndrome. Curr Opin Rheumatol. 2014;26:520–527.
   PubMed Web of Science ®Google Scholar
• Moreira I, Teixeira F, Martins Silva A, Vasconcelos C, Farinha F, Santos E. Frequent involvement of central nervous system in primary Sjogren syndrome. Rheumatol Int. 2015;35:289–294.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Macardle C, Weedon H, Beroukas D, Banovic T. Mucosal-associated invariant T cells are reduced and functionally immature in the peripheral blood of primary Sjögren's syndrome patients. Eur J Immunol. 2016;46(10):2444–2453.
   PubMed Web of Science ®Google Scholar
• Peterfalvi A, Gomori E, Magyarlaki T, et al. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol. 2008;20(12):1517–1525.
   PubMed Web of Science ®Google Scholar
• Zabijak L, Attencourt C, Guignant C, et al. Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients. Cancer Immunol Immunother. 2015;64:1601–1608.
   PubMed Web of Science ®Google Scholar
• Sundström P, Ahlmanner F, Akéus P, et al. Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-γ. J Immunol. 2015;195(7):3472–3481.
   PubMed Web of Science ®Google Scholar
• Won EJ, Ju JK, Cho YN, et al. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer. Oncotarget. 2016;7(46):76274–76290.
   PubMed Web of Science ®Google Scholar
• Kim JC, Jin HM, Cho YN, Kwon Y-S, Kee S-J, Park Y-W. Deficiencies of circulating mucosal-associated invariant T cells and natural killer T cells in patients with acute cholecystitis. J Korean Med Sci. 2015;30(5):606–611.
   PubMed Web of Science ®Google Scholar
• Kumar V, Sharma A. Innate immunity in sepsis pathogenesis and its modulation: New immunomodulatory targets revealed. J Chemother. 2008;20(6):672–683.
   PubMed Web of Science ®Google Scholar
• Grimaldi D, Le Bourhis L, Sauneuf B, et al. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med. 2014;40(2):192–201.
   PubMed Web of Science ®Google Scholar
• Szabo PA, Anantha RV, Shaler CR, McCormick JK, Haeryfar SM. CD1d- and MR1-restricted T cells in sepsis. Front Immunol. 2015;6:401. doi:10.3389/fimmu.2015.00401 https://doi.org/10.3389/fimmu.2015.00401 PMID:26322041
   PubMed Web of Science ®Google Scholar
• Kwon YS, Jin HM, Cho YN, , et al. Mucosal-associated invariant T cell deficiency in chronic obstructive pulmonary disease. COPD. 2015;9:1–7. [Epub ahead of print]
   PubMedGoogle Scholar
• Sugimoto C, Konno T, Wakao R, Fujita H, Fujita H, Wakao H. Mucosal-associated invariant T cell is a potential marker to distinguish fibromyalgia syndrome from arthritis. PLoS One. 2015;10(4):e0121124.
   PubMed Web of Science ®Google Scholar
• Ishimori A, Harada N, Chiba A, et al. Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma. Allergol Int. 2016;S1323–8930(16):30105–30108.
   Google Scholar
• Cui Y, Franciszkiewicz K, Mburu YK, et al. Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J Clin Invest. 2015;125(11):4171–4185.
   PubMed Web of Science ®Google Scholar
• Sugimoto C, Fujita H, Wakao H. Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modelling human diseases. World J Stem Cells. 2016;8(4):1581–1569.
   Web of Science ®Google Scholar
• Laugel B, Lloyd A, Meermeier EW, et al. Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system: Tools to study microbial antigen processing and presentation to human MR1-restricted T cells. J Immunol. 2016;197(3):971–982.
   PubMed Web of Science ®Google Scholar
• Meermeier EW, Laugel BF, Sewell AK, et al. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens. Nat Commun. 2016;7:12506.
   PubMed Web of Science ®Google Scholar
• Novak J, Dobrovolny J, Novakova L, Kozak T. The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol. 2014;80(4):271–275.
   PubMed Web of Science ®Google Scholar
• Jo YG, Choi HJ, Kim JC, , et al. Deficiencies of circulating Mucosal-associated invariant T cells and Natural Killer T cells in patients with multiple trauma. J Korean Med Sci. 2017;32(5):750–756.
   PubMed Web of Science ®Google Scholar
• Keller AN, Eckle SB, Xu W et al. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells. Nat Immunol. 2017;18(4):402–411.
   PubMed Web of Science ®Google Scholar
• Ammitzboll C, Bornsen L, Christensen JR, et al. Smoking reduces circulating CD26hiCD161hi MAIT cells in healthy individuals and patients with multiple sclerosis. J Leukoc Biol. 2017;101:1–10. [Epub ahead of print]. doi:10.1189/jlb.3A0616-267R. PMID:28049141
   PubMed Web of Science ®Google Scholar
• Seeff LB, Curto TM, Szabo G, et al. Herbal product use by a persons enrolled in the hepatitis C antiviral long-term treatment against Cirrhosis (HALT-C) Trial. Hepatology. 2008;47(2):605–612.
   PubMed Web of Science ®Google Scholar
• Polyak SJ, Ferenci P, Pawlotsky JM. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. Hepatology. 2013;57(3):1262–1271.
   PubMed Web of Science ®Google Scholar
• McClure J, Lovelace ES, Elahi S, Maurice NJ, Wagoner J, Dragavon J, et al. Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation. PLoS One. 2012;7(7):e41832.
   PubMed Web of Science ®Google Scholar
• Lovelace ES, Maurice NJ, Miller HW, et al. Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells. PLoS One. 2017;12(2):e0171139.
   PubMed Web of Science ®Google Scholar
• Mak JY, Xu W, Reid RC, et al. Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells. Nat Commun. 2017;8:14599. doi:10.1038/ncomms14599. https://doi.org/10.1038/ncomms14599 PMID:28272391
   PubMed Web of Science ®Google Scholar
• Chiba A, Tamura N, Yoshikiyo K, et al. Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus. Arthritis Res Ther. 2017;19(1):58. doi:10.1186/s13075-017-1257-5. https://doi.org/10.1186/s13075-017-1257-5 PMID:28288675
   PubMed Web of Science ®Google Scholar
• Conti P, Shaik-Dasthagirisaeb Y. Atherosclerosis: a chronic inflammatory disease mediated by mast cells. Cent Eur J Immunol. 2015;40(3):380–386.
   PubMed Web of Science ®Google Scholar
• Spirig R, Tsui J, Shaw S. The emerging role of TLRs and innate immunity in cardiovascular disease. Cardiol Res Pract. 2012;18:1394.
   Google Scholar
• Fergusson JR, Hühn MH, Swadling L, et al. CD161(int)CD8+ T cells: A novel population of highly functional, memory CD8+ T cells enriched within the gut. Mucosal Immunol. 2016;9(2):401–413.
   PubMed Web of Science ®Google Scholar
• Tang X, Jo J, Tan AT, et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol 2013;190:3142–3152.
   PubMed Web of Science ®Google Scholar
• Jeffery HC, van Wilgenburg B, Kurioka A, et al. Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. J Hepatol. 2016;64(5):1118–1127.
   PubMed Web of Science ®Google Scholar
• Hinks TS, Wallington JC, Williams AP, Djukanović R, Staples KJ, Wilkinson TM. Steroid-induced deficiency of mucosal-associated invariant T cells in the chronic obstructive pulmonary disease lung. Implications for non type able Haemophilus influenzae infection. Am J Respir Crit Care Med. 2016;194(10):1208–1218.
   PubMed Web of Science ®Google Scholar
• Lepore M, Kalinichenko A, Colone A, et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. Nat Commun. 2014;5:3866. doi:10.1038/ncomms4866. PMID:24832684
   PubMed Web of Science ®Google Scholar
• Kawachi I, Maldonado J, Strader C, Gilfillan S. MR1-Restricted V 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol. 2006;176:1618–1627.
   PubMed Web of Science ®Google Scholar
• McCulloch CA, Downey GP, El-Gabalawy H. Signalling platforms that modulate the inflammatory response: new targets for drug development. Nat Rev Drug Discov. 2006;5(10):864–876.
   PubMed Web of Science ®Google Scholar
• Keystone EC, Kavanaugh A. What to do with TNF failures. Expert Opin Drug Saf. 2005;4:149–155.
   PubMedGoogle Scholar
• Durham AL, Caramori G, Chung KF, Adcock IM. Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease. Transl Res. 2016;167(1):192–203.
   PubMed Web of Science ®Google Scholar
• Tominaga K, Yamagiwa S, Setsu T, et al. Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases. Biomed Res. 2017;38(2):111–121.
   PubMed Web of Science ®Google Scholar
• Salerno-Goncalves R, Luo D, Fresnay S, et al. Challenge of humans with wild-type Salmonella enterica serovar Typhi elicits changes in the activation and homing characteristics of mucosal-associated invariant T cells. Front Immunol. 2017;8:398. doi:10.3389/fimmu.2017.00398. PMID:28428786
   PubMed Web of Science ®Google Scholar
• Liu J, Brutkiewicz RR. The TLR9 signaling pathway regulates MR1-mediated bacterial antigen presentation in B cells. Immunology. 2017;152(2):232–242. doi:10.1111/imm.12759.
   PubMed Web of Science ®Google Scholar
• Lamichhane R, Ussher JE. Expression and trafficking of MR1. Immunology. 2017;151(3):270–279.
   PubMed Web of Science ®Google Scholar
• Paquin-Proulx D, Greenspun BC, Costa EA, et al. MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications. PLoS One. 2017 6;12(4):e0175345. doi:10.1371/journal.pone.0175345. PMID:28384290
   PubMed Web of Science ®Google Scholar
• Saito Y, Sugimoto C, Mituyama T, Wakao H. Epigenetic silencing of V(D)J recombination is a major determinant for selective differentiation of mucosal-associated invariant t cells from induced pluripotent stem cells. PLoS One. 2017;12(3):e0174699. doi:10.1371/journal.pone.0174699. PMID:28346544
   PubMed Web of Science ®Google Scholar
• Chiba A, Tajima R, Tomi C, Miyazaki Y, Yamamura T, Miyake S. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rheum. 2012;64(1):153–161.
   PubMedGoogle Scholar
• Keller AN, Corbett AJ, Wubben JM, McCluskey J, Rossjohn J. MAIT cells and MR1-antigen recognition. Curr Opin Immunol. 2017;46:66–74.
   PubMed Web of Science ®Google Scholar
• Moreira ML, Tsuji M, Corbett AJ, et al. MAIT-cells: A tailor-made mate in the ancient battle against infectious diseases? Immunol Lett. 2017;187:53–60.
   PubMed Web of Science ®Google Scholar
• Hinks TS. Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease. Immunology. 2016;148(1):1–12.
   PubMed Web of Science ®Google Scholar
• Sakala IG, Kjer-Nielsen L, Eickhoff CS, et al. Functional heterogeneity and antimycobacterial effects of mouse mucosal-associated invariant T cells specific for riboflavin metabolites. J Immunol. 2015;195 (2):587–601.
   PubMed Web of Science ®Google Scholar
• Cannons JL, Yu LJ, Hill B, Mijares LA, et al. SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity. 2004;21(5):693–706.
   PubMed Web of Science ®Google Scholar
• Dias J, Leeansyah E, Sandber JK. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokine. Proc Natl Acad Sci USA. 2017;114(27):E5434–E5443. pii: 201705759. doi:10.1073/pnas.1705759114. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Yong YK, Tan HY, Saeidi A, Rosmawati M, et al. Decrease of CD69 levels on TCR Va7.2þCD4þ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients. Innate Immun. 2017;23(5):459–467. doi:10.1177/1753425917714854. [Epub ahead of print]. PMID:28606013
   PubMed Web of Science ®Google Scholar
• Shaler CR, Choi J, Rudak PT, Memarnejadian A, et al. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. PLoS Biol. 2017 Jun 20; 15(6):e2001930. doi:10.1371/journal.pbio.2001930. eCollection 2017 Jun. PMID:28632753
   PubMed Web of Science ®Google Scholar